SEC 13F Intelligence

Endurant Capital Management LP / TMO

Endurant Capital Management LP’s Thermo Fisher Scientific Inc Position

Does Endurant Capital Management LP own Thermo Fisher Scientific Inc (TMO)? Not currently — the last reported position was 3.8K shares worth $2M in Q4 2023; the fund’s latest 13F (Q1 2024) no longer reports it.

Position Value
$2M
Q4 2023
Shares
3.8K
% of Portfolio
+11.55%
Quarters Held
6
position exited

Position History TMO

Reported value by quarter
Q1 ’19: $3MQ1 ’19Q2 ’21: $15MQ2 ’21Q4 ’22: $875,046Q4 ’22Q1 ’23: $2MQ1 ’23Q3 ’23: $7MQ3 ’23Q4 ’23: $2MQ4 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q4 20233.8K$2M+11.55%
Q3 202313.8K$7M+6.30%
Q1 20233.7K$2M+1.11%
Q4 20221.6K$875,046+0.36%
Q2 202129.7K$15M+4.11%
Q1 201910.5K$3M+1.14%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Endurant Capital Management LP’s full portfolio or all institutional holders of TMO.